NCT06038526 2026-05-20Evaluation of Canakinumab in High-Risk Former-SmokersOhio State University Comprehensive Cancer CenterPhase 2 Active not recruiting41 enrolled
NCT06815666 2026-03-04BAL Fluid Biomarkers in SarcomaUniversity Health Network, TorontoPhase 2 Recruiting70 enrolled